Putnam Investments’s Allergan Inc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-438,869
Closed -$93.3M 1616
2014
Q4
$93.3M Sell
438,869
-305,629
-41% -$60.8M 0.19% 120
2014
Q3
$133M Sell
744,498
-7,454
-1% -$1.24M 0.28% 86
2014
Q2
$127M Buy
751,952
+61,955
+9% +$9.65M 0.27% 87
2014
Q1
$85.6M Sell
689,997
-354,867
-34% -$43.2M 0.19% 126
2013
Q4
$116M Sell
1,044,864
-40,157
-4% -$3.84M 0.28% 90
2013
Q3
$98.1M Buy
1,085,021
+125,283
+13% +$11.2M 0.26% 100
2013
Q2
$80.8M Buy
+959,738
New +$99.6M 0.24% 111

Other funds holding AGN

Putnam Investments's AGN Position: Q1 2015 in Review

Putnam Investments sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 438,869 shares — an estimated $93.3M sold.

Putnam Investments first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $133M in Q3 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Putnam Investments reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Putnam Investments sold 438,869 Allergan Inc shares in Q1 2015, an estimated $93.3M.
  • Putnam Investments first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Putnam Investments's Allergan Inc position peaked at $133M in Q3 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Putnam Investments's 13F filing for Q1 2015, filed 15 May 2015.